CFP10–loaded PLGA nanoparticles as a booster vaccine confer protective immunity against Mycobacterium bovis

Zhengmin Liang ¹ , Miaoxuan Li ¹, Jiamin Ni ¹, Tariq Hussain ¹, Jiao Yao ¹, Yinjuan Song ¹, Yiduo Liu ¹, Haoran Wang ¹, Xiangmei Zhou ¹ *

Cited by CrossRef: 3

1- Ge X, Liang Z, Li K, Dong Y, Wang Y, Liu Y, Liu Z, Wang H, Nan Y, Chen S, Li L, Guo Y, Zhou X. Selenium nanoparticles enhance mucosal immunity against Mycobacterium bovis infection. International Immunopharmacology. 2024;137:112384 [Crossref]

2- Vega E, Burgos J, Souto E, García M, Pujol M, Sánchez-López E. Biodegradable nanoplatforms for antigen delivery: part I – state of the art review of polymeric nanoparticles for cancer immunotherapy. Expert Opinion on Drug Delivery. 2024;21(8):1251 [Crossref]

3- Szachniewicz M, Neustrup M, van den Eeden S, van Meijgaarden K, Franken K, van Veen S, Koning R, Limpens R, Geluk A, Bouwstra J, Ottenhoff T. Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model – A comparison. International Journal of Pharmaceutics. 2024;666:124842 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons